Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The Hairless gene is crucial for healthy skin and hair growth.

ILC1 cells contribute to hair loss in alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Hair growth phase in mice weakens certain immune responses.

Increasing Smurf2 hinders hair follicle stem cell differentiation and wound healing.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

The skin of both rat strains showed similar lectin binding patterns.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Age-related immune changes significantly affect disease development in other systems.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Controlling Tslp can improve health in AEC syndrome patients.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

3D spheroid culture makes stem cells better at reducing inflammation.

Targeting regulatory T cells may help treat age-related diseases.

Immune system changes may contribute to female pattern hair loss.

Innate lymphoid cells help us understand and manage allergic diseases better.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Type 2 diabetes slows down skin and hair renewal by blocking important stem cell activation in mice.